Protein Glycosylation Analysis Using the Agilent Cary 630 FTIR Spectrometer

Importance of Protein Glycosylation Analysis

Protein glycosylation is a critical quality attribute for therapeutic proteins, affecting stability, solubility, immunogenicity, and biological activity. Monitoring glycan structures and occupancy is essential during biopharmaceutical development and manufacturing to ensure safety and efficacy of monoclonal antibodies and other glycoprotein drugs.

Study Objectives and Overview

This application note presents a streamlined FTIR spectroscopy workflow using the Agilent Cary 630 spectrometer to detect and compare glycosylation profiles in monoclonal antibodies and standard glycoproteins. The goals are to demonstrate a rapid, nondestructive method for global glycosylation analysis and to evaluate its utility in distinguishing innovator and biosimilar products.

Methodology

Protein samples (5 mg/mL) were buffer-exchanged into water via spin-desalting columns to remove interfering excipients. Fifteen microliters of each sample were applied directly onto the diamond ATR crystal of the Cary 630. Spectra were acquired over 4000–650 cm⁻¹ (140 sample scans, 128 background scans, 2 cm⁻¹ resolution, triangular apodization) using Agilent MicroLab Expert software. Water background subtraction, baseline correction, Savitzky–Golay smoothing, and normalization were applied before integrating the 1179–965 cm⁻¹ glycan region.

Used Instrumentation

• Agilent Cary 630 FTIR spectrometer with diamond ATR accessory
• Agilent MicroLab Expert software version 1.1.0.1
• Thermo Fisher Zeba Spin Desalting Columns and Millipore Milli-Q water system

Main Results and Discussion

Spectra exhibited characteristic amide I (1600–1700 cm⁻¹) and amide II (1470–1570 cm⁻¹) bands for protein backbone, while the glycan absorption appeared in the 1200–950 cm⁻¹ window. Desalting effectively removed buffer signals, revealing clear glycan peaks. Integration of the 1179–965 cm⁻¹ region correlated with known glycosylation levels in fetuin, α₁-acid glycoprotein, ribonuclease B, and mAbs. PNGase F digestion reduced glycan band intensity, confirming specificity. Innovator and biosimilar mAbs displayed comparable peak areas, illustrating the method’s applicability for batch comparison.

Benefits and Practical Applications

• Minimal sample preparation and no labeling requirements
• Rapid, nondestructive analysis compatible with intact proteins
• Quantitative global glycosylation screening for quality control
• Capability to differentiate product variants and biosimilars
• Streamlined data processing with automated software routines

Future Trends and Opportunities

• Integration of FTIR with chemometric models for predictive glyco-profiling
• High-throughput ATR-FTIR platforms for inline bioprocess monitoring
• Expansion to multiplexed analysis of other post-translational modifications
• Coupling with machine learning for automated batch release testing
• Development of standardized spectral libraries for regulatory compliance

Conclusion

The Agilent Cary 630 FTIR method provides a fast, reliable, and nondestructive approach to assess global glycosylation in biopharmaceutical proteins. Its minimal sample handling and clear glycan signature enable efficient quality control of monoclonal antibodies and glycoproteins, supporting consistent manufacturing and comparability studies.

References

1. He, M.; Zhou, X.; Wang, X. Glycosylation: Mechanisms, Biological Functions and Clinical Implications. Signal Transduction and Targeted Therapy 2024, 9(1), 194.
2. Derenne, A.; Derfoufi, K. M.; Cowper, B.; Delporte, C.; Goormaghtigh, E. FTIR Spectroscopy as an Analytical Tool to Compare Glycosylation in Therapeutic Monoclonal Antibodies. Analytica Chimica Acta 2020, 1112, 62–71.
3. Khajehpour, M.; Dashnau, J. L.; Vanderkooi, J. M. Infrared Spectroscopy Used to Evaluate Glycosylation of Proteins. Analytical Biochemistry 2006, 348(1), 40–48.
4. Derenne, A.; Derfoufi, K.-M.; Cowper, B.; Delporte, C.; Butré, C. I.; Goormaghtigh, E. Analysis of Glycoproteins by ATR-FTIR Spectroscopy: Comparative Assessment. Methods in Molecular Biology 2021, 2271, 361–374.
5. Yang, Y.; Wang, G.; Song, T.; Lebrilla, C. B.; Heck, A. J. R. Resolving the Micro-Heterogeneity and Structural Integrity of Monoclonal Antibodies by Hybrid Mass Spectrometric Approaches. mAbs 2017, 9(4), 638–645.